At the news
? BEARISHIMPACT 4/10 144 filed Jun 29, 2026 at 17:50 ET
Atlas Venture Fund XI, L.P. and Atlas Venture Opportunity Fund I, L.P., two affiliated venture capital funds, filed Form 144 notices on June 29, 2026, indicating intent to sell a combined 102,969 shares of Dyne Therapeutics (DYN) valued at approximately $2.16 million. As early investors, these sales represent a partial exit by a major insider, though the dollar amount is modest relative to DYN's $3.5B market cap.
- Atlas Venture Fund XI, L.P. files Form 144 to sell 102,969 shares of DYN common stock.
- Atlas Venture Opportunity Fund I, L.P. also files a Form 144 on the same date (share count not specified in available text).
- Total proposed sale value is approximately $2,156,170.86 based on the first filing.
- Shares were acquired in a private placement on July 31, 2020.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access